The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Chazova I.E.

Federal State budget organization National Medical Research Center of Cardiology of the Ministry of healthcare of the Russian Federation, The Institute of Clinical Cardiology, Moscow, Russia

Martynyuk T.V.

The Institute of Clinical Cardiology named after A.L. Myasnikov, Federal State Institution «National Medical Research Center of Сardiology», Moscow, Russia

Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)

Authors:

Chazova I.E., Martynyuk T.V.

More about the authors

Journal: Therapeutic Archive. 2016;88(10): 63‑73

Read: 16691 times


To cite this article:

Chazova IE, Martynyuk TV. Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2). Therapeutic Archive. 2016;88(10):63‑73. (In Russ.)
https://doi.org/10.17116/terarkh201688663-73

Recommended articles:
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Virus-associated progesterone-resistant chro­nic endo­metritis — the onco­risk situation?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):25-30
Modern approaches to cystic lung diseases diagnosis. Journal of Respiratory Medi­cine. 2025;(1):30-37
Primary bile acid synthesis diso­rders. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):71-90
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77

References:

  1. Chazova I, Avdeev S, Tsareva N, Volkov A, Martynyuk T, Nakonechnikov S. Clinical guidelines on the diagnosis and treatment of pulmonary hypertension. Terapevticheskii arkchiv. 2014;9:4-23. (In Russ.)
  2. Mereles D, Ehlken N, Kreuscher S et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114:1482-1489. doi:10.1161/CIRCULATIONAHA.106.618397
  3. The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J. 2003;24:761-781.  doi:10.1016/S0195-668X(03)00098-8
  4. Galie N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015;46(4):903-975.  doi:10.1183/13993003.01032-2015
  5. Mershin K, Akchurin R. Chronic thromboembolic hypertension. In: Pulmonary hypertension. Ed by Chazova I, Martynyuk T. Moscow: Practica; 2015. (In Russ.)
  6. Chernyavsky A. Chronic postembolic hypertension. In: Pulmonary hypertension. Ed by Avdeev S. Moscow; GEOTAR-Media; 2015. (In Russ.)
  7. Keith McNeil, John Dunning. Chronic thromboembolic pulmonary hypertension (CTEPH) Heart. 2007;93(9):1152-1158. doi:10.1136/hrt.2004.053603
  8. Berman M, Tsui S, Vuylsteke A et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg. 2008;86:1261-1267. doi:10.1016/j.athoracsur.2008.06.037
  9. Mayer E, Jenkins D, Lindner J et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141:702-710.  doi:10.1016/j.jtcvs.2010.11.024
  10. Kim NH, Delcroix M, Jenkins DP et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62:D92-D99.  doi:10.1016/j.jacc.2013.10.024
  11. Thistlethwaite PA, Madani MM, Kemp AD et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg. 2006;82:2139-2145. doi:10.1016/j.athoracsur.2006.07.020
  12. Wilkens H, Lang I, Behr J et al. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension. Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011. Respirhttp://www.ncbi.nlm.nih.gov/pubmed/23978639Investig. 2013;51(3):134-146.  doi:10.1016/S0167-5273(11)70493-4
  13. Mehta S, Helmersen D, Provencher S et al. Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J. 2010;17(6):301-334.  doi:10.1155/2010/704258
  14. Pepke-Zaba J, Hoeper MM, Humbert M. Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Respir J. 2013;41:8-9.  doi:10.1183/09031936.00181212
  15. Mershin K, Martynyuk T. Place of medical therapy in the treatment of chronic thromboembolic pulmonary hypertension. Evraziiskii zhurnal. 2014;1:113-118. (In Russ.)
  16. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113:2011-2020. doi:10.1161/CIRCULATIONAHA.105.602565
  17. Ghofrani HA, Hoeper MM, Halank M et al. Riociguat for chronic Thromboembolic pulmonary hypertension and pulmonary arterial hypertension: A phase II study. Eur Respir J. 2010;36:792-799.  doi:10.1183/09031936.00182909
  18. Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369:319-329.  doi:10.1056/NEJMoa1209657
  19. Skoro-Sajer N, Bonderman D, Wiesbauer F et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2007;5:483-489.  doi:10.1111/j.1538-7836.2007.02394.x
  20. Olschewski H, Simonneau G, Galiè N et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347(5):322-329.  doi:10.1056/NEJMoa020204
  21. Jaı¨s X, D’Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52:2127-2134. doi:10.1016/j.jacc.2008.08.059
  22. Galiè N, Ghofrani HA, Torbicki A et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353(20):2148-2157. doi:10.1056/NEJMoa050010
  23. Reichenberger F, Voswinckel R, Enke B et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2007;30:922-927.  doi:10.1183/09031936.00039007
  24. Kataoka M, Inami T, Hayashida K et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:756-762.  doi:10.1161/CIRCINTERVENTIONS.112.971390
  25. Sugimura K, Fukumoto Y, Satoh K et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76:485-488.  doi:10.1253/circj.CJ-11-1217
  26. Danilov N, Matchin Yu, Martynyuk T, eds. Transluminal balloon angioplasty of pulmonary arteries in patients with inoperable chronic thromboembolic pulmonary hypertension (first experience in Russia). Consilium medicum. 2015;10:61-66. (In Russ.)
  27. Inami T, Kataoka M, Shimura N et al. Pulmonary edema predictive scoring index (PEPSI), a new indexto predict risk of reperfusion pulmonary edema and improvement of hemodynamicsin percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv. 2013;6:725-736.  doi:10.1016/j.jcin.2013.03.009

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.